ALK-Abelló A/S
ALK-Abelló A/S
Share · US0016281067 (OTC)
Overview
No Price
n/a
Company Profile for ALK-Abelló A/S Share
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
Get up to date insights from finAgent about ALK-Abelló A/S

Company Data

Name ALK-Abelló A/S
Company ALK-Abelló A/S
Website https://www.alk.net
Primary Exchange OTC UTC
ISIN US0016281067
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Carsten Hellmann
Country Denmark
Currency USD
Employees 2,6 T
Address Boge Alle 6-8, 2970 Horsholm
IPO Date 2013-09-05

Ticker Symbols

Name Symbol
Over The Counter AKABY
More Shares
Investors who hold ALK-Abelló A/S also have the following shares in their portfolio:
EIT Environmental Development Group Co.,Ltd
EIT Environmental Development Group Co.,Ltd Share
Federal Home Loan Mortgage Corporation
Federal Home Loan Mortgage Corporation Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025